ConductScience.org, home

Paper39258338

A model-based approach using GSK3772847, an anti-interleukin-33 receptor monoclonal antibody, as a showcase to predict SC administration PK and free target dynamics based on PK and total target measurements after IV administration.

Berkhout J and 3 others. CPT Pharmacometrics Syst Pharmacol, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. A model-based approach using GSK3772847, an anti-interleukin-33 receptor monoclonal antibody, as a showcase to predict SC administration PK and free target dynamics based on PK and total target measurements after IV administration. Papers, record 39258338. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39258338

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A model-based approach using GSK3772847, an anti-interleukin-33 receptor monoclonal antibody, as a showcase to predict SC administration PK and free target dynamics based on PK and total target measurements after IV administration.
PubMed
Journal
CPT Pharmacometrics Syst Pharmacol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-07-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Berkhout JJanhttps://orcid.org/0009-0003-2448-7829
2Fairman DDavehttps://orcid.org/0000-0002-7756-0212
3van Noort MMartijnhttps://orcid.org/0009-0004-7016-2846
4van Steeg TJTamara Jhttps://orcid.org/0000-0003-1387-1369

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Administration, IntravenousMajor topic
Antibodies, MonoclonalMajor topic
Models, BiologicalMajor topic
Humans
Injections, Subcutaneous
Interleukin-1 Receptor-Like 1 Protein
Interleukin-33
Antibodies, Monoclonal, Humanized

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
NCT02345928Janssen Research and DevelopmentPubMed
NCT03207243GSKPubMed
NCT03393806GSKPubMed
NCT04366349GSKPubMed

Source PubMed

Download CSV of grants

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121165681Impact of dose selection on parameter estimation using a rapid binding approximation model of target-mediated drug disposition.J Pharmacokinet Pharmacodyn2011https://conductscience.org/library/papers/21165681PubMed
231044558NONMEM Tutorial Part II: Estimation Methods and Advanced Examples.CPT Pharmacometrics Syst Pharmacol2019https://conductscience.org/library/papers/31044558PubMed
332415720The first-in-human study of CNTO 7160, an anti-interleukin-33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis.Br J Clin Pharmacol2020https://conductscience.org/library/papers/32415720PubMed
433918602Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as Total.Pharmaceutics2021https://conductscience.org/library/papers/33918602PubMed
537779541IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trial.J Allergy Clin Immunol Glob2022https://conductscience.org/library/papers/37779541PubMed
628109128Population Pharmacokinetics and Pharmacodynamics of Benralizumab in Healthy Volunteers and Patients With Asthma.CPT Pharmacometrics Syst Pharmacol2017https://conductscience.org/library/papers/28109128PubMed
726225261A Tutorial on Target-Mediated Drug Disposition (TMDD) Models.CPT Pharmacometrics Syst Pharmacol2015https://conductscience.org/library/papers/26225261PubMed
825707966Utility of free and total target measurements as target engagement and efficacy biomarkers in biotherapeutic development--opportunities and challenges.J Clin Pharmacol2015https://conductscience.org/library/papers/25707966PubMed
924287601Mechanistic pharmacokinetic/target engagement/pharmacodynamic (PK/TE/PD) modeling in deciphering interplay between a monoclonal antibody and its soluble target in cynomolgus monkeys.AAPS J2014https://conductscience.org/library/papers/24287601PubMed
1019505189Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic-pharmacodynamic modeling of biologics.Expert Opin Drug Metab Toxicol2009https://conductscience.org/library/papers/19505189PubMed
1120818831Population pharmacokinetics of therapeutic monoclonal antibodies.Clin Pharmacokinet2010https://conductscience.org/library/papers/20818831PubMed
1220669044Target-mediated drug disposition model for drugs that bind to more than one target.J Pharmacokinet Pharmacodyn2010https://conductscience.org/library/papers/20669044PubMed
1315212851Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming.Comput Methods Programs Biomed2004https://conductscience.org/library/papers/15212851PubMed
1411999290General pharmacokinetic model for drugs exhibiting target-mediated drug disposition.J Pharmacokinet Pharmacodyn2001https://conductscience.org/library/papers/11999290PubMed
1526645407Population pharmacokinetic and exposure-response analysis for trastuzumab administered using a subcutaneous "manual syringe" injection or intravenously in women with HER2-positive early breast cancer.Cancer Chemother Pharmacol2016https://conductscience.org/library/papers/26645407PubMed
1626445140Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab.Int J Clin Pharmacol Ther2015https://conductscience.org/library/papers/26445140PubMed
1716023764PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.Comput Methods Programs Biomed2005https://conductscience.org/library/papers/16023764PubMed
1824837591A model-based meta-analysis of monoclonal antibody pharmacokinetics to guide optimal first-in-human study design.MAbs2014https://conductscience.org/library/papers/24837591PubMed
1931859459The pharmacology and therapeutic applications of monoclonal antibodies.Pharmacol Res Perspect2019https://conductscience.org/library/papers/31859459PubMed
2021622864IL-13 antibodies influence IL-13 clearance in humans by modulating scavenger activity of IL-13Rα2.J Immunol2011https://conductscience.org/library/papers/21622864PubMed

See all 30 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
39258338
A model-based approach using GSK3772847, an anti-interleukin-33 receptor monoclonal antibody, as a showcase to predict SC administration PK and free target dynamics based on PK and total target measurements after IV administration.
CPT Pharmacometrics Syst Pharmacol2025https://conductscience.org/library/papers/39258338

Source PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL3390865PubTator's text mininghttps://conductscience.org/library/genes/90865NCBI Gene
IL33R9173PubTator's text mininghttps://conductscience.org/library/genes/9173NCBI Gene
ST26761PubTator's text mininghttps://conductscience.org/library/genes/6761NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39258338

GET https://conductscience.org/api/papers/v1/39258338/references?page=2